7 / 10
Page 55
conferenceseries
.com
Volume 7, Issue 3 (Suppl)
J Palliat Care Med, an open access journal
ISSN: 2165-7386
Palliative Care 2017
June 21- 22, 2017
3
rd
International Conference on
June 21- 22, 2017 | Philadelphia, USA
Palliative Care & Hospice Nursing
J Palliat Care Med 2017, 7:3(Suppl)
DOI: 10.4172/2165-7386-C1-009
THEEFFECTIVENESSOFFOUR-FACTORPSYCHOTHERAPYINTHEDECREASEOFCORTISOL
LEVEL
Farah Lotfi Kashani
a
, ShahramVaziri
a
and
Yashar Vaziri
b
a
Islamic Azad University, Iran.
b
Tehran University of Medical Sciences, Iran
M
any Patients with cancer are disturbed about the possibility of recurrence, death, body image and other psychological problems.
These stresses can increase cortisol level and lead to suppression of immune – system strength. The important role of cortisol
level in regulating immune- system has well documented. The aim of this research was to assess the effectiveness of four-factor
psychotherapy in decreasing the level of cortisol in women with breast cancer. The sample comprised 25 women diagnosed with
breast cancer who were selected using voluntary sampling and were randomly assigned to the experimental and control groups.
Groups were assessed in terms of serum levels of cortisol before and after the intervention. The experimental group underwent 12
sessions of four-factor psychotherapy whereas the control group received no intervention. The result of co-variance analysis indicated
that the four-factor psychotherapy is effective in decreasing the cortisol’s level of women with breast cancer. It can be concluded that
the four-factor psychotherapy by reducing cortisol levels and also decreasing physical and mental exhaustion contribute significantly
to the recovery of patients.
THE CHAMPLAIN SYMPTOM MANAGEMENT KIT: ENHANCING EOL CARE BY PROVIDING
TIMELYACCESS TO MEDICATIONS AND SUPPLIES IN THE HOME
France Perusse
a
, Genevieve Lalumiere
a
and
Paula Greco
a
a
Champlain CCAC, France
A
dequate pain and symptom management is an essential component of palliative and end-of-life care and has a direct impact on
patient and caregiver experience. In September 2014, the Champlain CCAC, in collaboration with regional pharmacies, service
provider organizations, the Regional Palliative Consultation Team and community palliative care physicians, introduced a Champlain
Wide Pain and SymptomManagement Kit (SMK). The SMK is a standard package of medications and related medical supplies placed
in the home of a patient who is approaching the end-of-life for the purpose of relieving unanticipated or rapidly escalating symptoms
in a timely manner.
The overall purpose of the Kit is to facilitate pain and symptom management at the end of life by providing timely access to
medications and supplies, therefore optimizing patients’ chances of remaining at home until death; enhancing informal caregiver
support in the home; and enabling nurses to manage symptoms without needing immediate access to a physician, which is often
difficult.
One year after implementation, a robust evaluation was completed. The results demonstrate a positive impact of the Kit on
patients, caregivers, and provider experience, including reduction of caregiver anxiety and increased self-efficacy. The results
also demonstrate a positive impact on a number of outcome measures, such as reduced emergency department visits and hospital
admissions, and increased patient deaths in their preferred location.